Interleukin-10 provides direct trophic support to neurons

Journal of Neurochemistry

Volumn 110, Issue 5, 2009, Pages 1617-1627

  Zhou, Zhigang ^b   Peng, Xiangmin ^b   Insolera, Ryan ^b   Fink, David J ^b   Mata, Marina ^a,b  

^a 5027 BSRB ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Cytokine; Development; Interleukin 10; Neurotrophin

Indexed keywords

CASPASE; CYTOCHROME C; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; JANUS KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P50; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DNA SEQUENCE; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MACROGLIA; MITOCHONDRION; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL CORD NERVE CELL; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; CELL PROLIFERATION; CELLS, CULTURED; INFLAMMATION MEDIATORS; INTERLEUKIN-10; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RECEPTORS, INTERLEUKIN-10; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 68949212050     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06263.x     Document Type: Article

References (39)

1. Bachis A., Colangelo A. M., Vicini S., Doe P. P., De Bernardi M. A., Brooker G. Mocchetti I. (2001) Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J. Neurosci. 21, 3104 3112.
2. Bethea J. R., Nagashima H., Acosta M. C., Briceno C., Gomez F., Marcillo A. E., Loor K., Green J. Dietrich W. D. (1999) Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 16, 851 863.
3. Boyd Z. S., Kriatchko A., Yang J., Agarwal N., Wax M. B. Patil R. V. (2003) Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress. Invest. Ophthalmol. Vis. Sci. 44, 5206 5211.
4. Brewer K. L., Bethea J. R. Yezierski R. P. (1999) Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp. Neurol. 159, 484 493.
5. Choi D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623 634.
6. Dietrich W. D., Busto R. Bethea J. R. (1999) Postischemic hypothermia and IL-10 treatment provide long-lasting neuroprotection of CA1 hippocampus following transient global ischemia in rats. Exp. Neurol. 158, 444 450.
7. Du Y., Bales K. R., Dodel R. C., Hamilton-Byrd E., Horn J. W., Czilli D. L., Simmons L. K., Ni B. Paul S. M. (1997) Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl Acad. Sci. USA 94, 11657 11662.
8. Frei K., Lins H., Schwerdel C. Fontana A. (1994) Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152, 2720 2728.
9. Grad J. M., Zeng X. R. Boise L. H. (2000) Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr. Opin. Oncol. 12, 543 549.
10. Ho A. S., Liu Y., Khan T. A., Hsu D. H., Bazan J. F. Moore K. W. (1993) A receptor for interleukin 10 is related to interferon receptors. Proc. Natl Acad. Sci. USA 90, 11267 11271.
11. Hoffmann A. Baltimore D. (2006) Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210, 171 186.
12. Howard M., O'Garra A., Ishida H., de Waal Malefyt R. de Vries J. (1992) Biological properties of interleukin 10. J. Clin. Immunol. 12, 239 247.
13. Israel A. (2000) The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol. 10, 129 133.
14. Jander S., Pohl J., D'Urso D., Gillen C. Stoll G. (1998) Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am. J. Pathol. 152, 975 982.
15. Kassed C. A., Willing A. E., Garbuzova-Davis S., Sanberg P. R. Pennypacker K. R. (2002) Lack of NF-kappaB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning. Exp. Neurol. 176, 277 288.
16. Kelly A., Lynch A., Vereker E., Nolan Y., Queenan P., Whittaker E., O'Neill L. A. Lynch M. A. (2001) The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK. J. Biol. Chem. 276, 45564 45572.
17. Kluck R. M., Bossy-Wetzel E., Green D. R. Newmeyer D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132 1136.
18. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S. Wang X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479 489.
19. Lin Y. Z., Yao S. Y., Veach R. A., Torgerson T. R. Hawiger J. (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270, 14255 14258.
20. Liu Y., Wei S. H., Ho A. S., de Waal Malefyt R. Moore K. W. (1994) Expression cloning and characterization of a human IL-10 receptor. J. Immunol. 152, 1821 1829.
21. Maggirwar S. B., Sarmiere P. D., Dewhurst S. Freeman R. S. (1998) Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J. Neurosci. 18, 10356 10365.
22. Mao X., Moerman A. M., Lucas M. M. Barger S. W. (1999) Inhibition of the activity of a neuronal kappaB-binding factor by glutamate. J. Neurochem. 73, 1851 1858.
23. Massa P. T., Aleyasin H., Park D. S., Mao X. Barger S. W. (2006) NF-kappaB in neurons? The uncertainty principle in neurobiology. J. Neurochem. 97, 607 618.
24. Mattson M. P. (2005) NF-kappaB in the survival and plasticity of neurons. Neurochem. Res. 30, 883 893.
25. Moore K. W., de Waal Malefyt R., Coffman R. L. O'Garra A. (2001) Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683 765.
26. Namura S., Zhu J., Fink K., Endres M., Srinivasan A., Tomaselli K. J., Yuan J. Moskowitz M. A. (1998) Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18, 3659 3668.
27. O'Shea J. J. Murray P. J. (2008) Cytokine signaling modules in inflammatory responses. Immunity 28, 477 487.
28. Parcellier A., Tintignac L. A., Zhuravleva E. Hemmings B. A. (2008) PKB and the mitochondria: AKTing on apoptosis. Cell. Signal. 20, 21 30.
29. Peineau S., Taghibiglou C., Bradley C. et al. (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53, 703 717.
30. Perkins N. D. Gilmore T. D. (2006) Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ. 13, 759 772.
31. Rodgers E. E. Theibert A. B. (2002) Functions of PI 3-kinase in development of the nervous system. Int. J. Dev. Neurosci. 20, 187 197.
32. Romashkova J. A. Makarov S. S. (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86 90.
33. Shin H. M., Kim M. H., Kim B. H., Jung S. H., Kim Y. S., Park H. J., Hong J. T., Min K. R. Kim Y. (2004) Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett. 571, 50 54.
34. Tobe M., Isobe Y., Tomizawa H., Nagasaki T., Takahashi H., Fukazawa T. Hayashi H. (2003) Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation. Bioorg. Med. Chem. 11, 383 391.
35. Weber-Nordt R. M., Henschler R., Schott E., Wehinger J., Behringer D., Mertelsmann R. Finke J. (1996) Interleukin-10 increases Bcl-2 expression and survival in primary human CD34 + hematopoietic progenitor cells. Blood 88, 2549 2558.
36. Wu Y. Y. Bradshaw R. A. (2000) Activation of the Stat3 signaling pathway is required for differentiation by interleukin-6 in PC12-E2 cells. J. Biol. Chem. 275, 2147 2156.
37. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P. Wang X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129 1132.
38. Yoshimura T., Kawano Y., Arimura N., Kawabata S., Kikuchi A. Kaibuchi K. (2005) GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120, 137 149.
39. Yu Z., Zhou D., Bruce-Keller A. J., Kindy M. S. Mattson M. P. (1999) Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci. 19, 8856 8865.